Bolus Versus Continuous Infusion of Meropenem

NCT03452839 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

607

Enrollment

OTHER

Sponsor class

Conditions

Antibiotic Resistant Infection
Critical Illness

Interventions

DRUG: Meropenem

Sponsor

Università Vita-Salute San Raffaele